About Us

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

Every day we come to work with a focus on building and supporting technology that helps people live healthier, happier lives. It began over 30 years ago with the invention of a machine that helped people breathe easier and sleep better. And it continues today with digital health solutions that help keep people out of the hospital.

Our drive to innovate

We’re leading the way in cloud-connected medical devices that transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.

• Sleep apnea: Cloud-connected CPAP machines, equipment, and digital health technologies used to treat sleep apnea.
• Respiratory care: Cloud-connected bilevel devices, ventilators, and digital health technologies used to manage COPD and other respiratory diseases.
• Software as a service (SaaS): A network of out-of-hospital healthcare management solutions designed to help providers deliver more personalized care, measurable results, and improved health outcomes.

Our purpose

Our team of over 10,000 ResMedians is making a positive impact on millions of lives every day in more than 140 countries. We’re passionate about being accountable to the communities we’re in. Our work is guided by an environmental policy that promotes waste and pollution reduction, the use of reduced-impact materials and fair labor practices across the globe. Our strategy is to change the lives of over 250 million people in 2025.

• 174+ million lives changed in the past 12 months by a ResMed device, mask, accessory, or digital health solution
• 18+ billion nights of clinical respiratory data
• 24.5+ million cloud-connectable devices in market
• 7.8+ million myAir users self-monitor their CPAP treatment
• 27+ million patients in AirView monitoring ecosystem

Recent Awards

• 2022: Mick Farrell named #1 Health Technology CEO of 2022
• 2019-2023: One of America’s “Management Top 250” companies (The Wall Street Journal)
• 2020-2024: One of “America’s Most Responsible Companies” (Newsweek/Statista)
• 2019: “Dealmaker of the Year” for ResMed’s successful acquisitions like MatrixCare and Propeller Health (Medtech Insight/Pharma Intelligence)
• 2019: #1 “JUST 100” company in the “Healthcare Equipment & Services” industry, for corporate citizenship (Forbes/JUST Capital)
• 2019: “Best Product Design” awards for AirFit N30i and AirFit P30i tube-up CPAP masks (Good Design Australia)
• 2019: Brightree Home Health and Hospice EMR awarded “Best Overall Health Administration Software” (MedTech Breakthrough)
• 2017-2019: MatrixCare solutions awarded “Best In KLAS,” highest-ever score for the Long-Term Care category (KLAS)